Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 10;386(10):998-999.
doi: 10.1056/NEJMc2116999. Epub 2022 Jan 26.

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

Dror Mevorach  1 , Emilia Anis  2 , Noa Cedar  2 , Tal Hasin  3 , Michal Bromberg  4 , Lital Goldberg  2 , Elchanan Parnasa  5 , Rita Dichtiar  4 , Yael Hershkovitz  4 , Nachman Ash  2 , Manfred S Green  6 , Lital Keinan-Boker  4 , Sharon Alroy-Preis  7
Affiliations

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

Dror Mevorach et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Myocarditis after BNT162b2 Vaccination in Adolescents 12 to 15 Years of Age, According to Sex and Timing of Diagnosis.
Shown is the timing of diagnosis of myocarditis, according to sex, among adolescents within 30 days after receipt of the second dose of the BNT162b2 vaccine. Myocarditis developed in one male adolescent 5 days after receipt of the first vaccine dose (data not shown).
See this image and copyright information in PMC

References

    1. Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med 2021;385:2140-2149. - PMC - PubMed
    1. Brighton Collaboration of the Task Force for Global Health. Myocarditis/pericarditis case definition. 2021. (https://brightoncollaboration.us/myocarditis-case-definition-update/).
    1. Wallace M, Oliver S. COVID-19 mRNA vaccines in adolescents and young adults: benefit-risk discussion. Meeting of the Advisory Committee on Immunization Practices (ACIP). Atlanta: Centers for Disease Control and Prevention, June 23, 2021. (https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/05-C...).
    1. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med 2021;385:239-250. - PMC - PubMed

Publication types